![Mohammad Hirmand](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mohammad Hirmand
Director/Board Member at
WHITEHAWK THERAPEUTICS, INC.
Net worth: - $ as of 29/06/2026
Profile
Dr. Mohammad Hirmand, MD, is a Chief Medical Officer & Executive Vice President at Turning Point Therapeutics, Inc. Dr. Hirmand was previously employed as a Vice President-Clinical Development by Medivation LLC (California), an Associate Director-Clinical Research by Amgen, Inc., a Senior Director-Clinical Development by ARCA biopharma, Inc., a Manager-Market Development & Product Evaluation by Innoviva, Inc., a Senior Director-Clinical Development by Nuvelo, Inc., a Chief Medical Officer by Peloton Therapeutics, Inc., a Director-Oncology Development by SuperGen, Inc., a Principal by Theravance Biopharma US, Inc., and a Manager-Clinical Data by Tularik, Inc. He received his undergraduate degree from Cornell University and a doctorate degree from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/06/2026 | 0 ( -.--% ) | - $ | 29/06/2026 |
Mohammad Hirmand active positions
| Companies | Position | Start |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Director/Board Member | 26/03/2023 |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Founder | 31/07/2022 |
Atavistik Bio, Inc.
 Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Director/Board Member | - |
Former positions of Mohammad Hirmand
| Companies | Position | End |
|---|---|---|
| TURG POIN | Chief Tech/Sci/R&D Officer | 31/07/2022 |
| PELOTON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/12/2019 |
| MEDIVATION INC | Chief Operating Officer | 30/09/2015 |
Theravance Biopharma US, Inc.
 Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Corporate Officer/Principal | - |
| ARCA BIOPHARMA | Corporate Officer/Principal | - |
Training of Mohammad Hirmand
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
39
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs, diagnostics and other therapeutic products | Health Technology |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
ARCA biopharma, Inc.
 ARCA biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Commercial Services |
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Health Technology |
- Stock Market
- Insiders
- Mohammad Hirmand
Choose MarketScreener 
